Logo image
Functional Regulation of ClC-3 in the migration of vascular smooth muscle cells
Journal article   Open access   Peer reviewed

Functional Regulation of ClC-3 in the migration of vascular smooth muscle cells

Sindura B Ganapathi, Shun-Guang Wei, Angelika Zaremba, Fred S Lamb and Stephen B Shears
Hypertension (Dallas, Tex. 1979), Vol.61(1), pp.174-179
01/2013
DOI: 10.1161/HYPERTENSIONAHA.112.194209
PMCID: PMC3521842
PMID: 23150504
url
https://doi.org/10.1161/HYPERTENSIONAHA.112.194209View
Published (Version of record) Open Access

Abstract

Migration of vascular smooth muscle cells (VSMC) into neointima contributes to atherosclerosis and restenosis. This migration requires co-ordinated plasmalemmal fluxes of water and ions. Here, we show that aortic VSMC migration is dependent upon the regulation of transmembrane Cl − flux by ClC-3, a Cl − channel/transporter. The contribution of ClC-3 to plasmalemmal Cl − current was studied in VSMC by electrophysiological recordings. Cl − current was negligible in cells perfused with zero [Ca 2+ ]. Raising intracellular [Ca 2+ ] to 0.5 μM activated a Cl − current (I Cl.Ca ), approximately half of which was eliminated upon inhibition by KN-93 of calmodulin-dependent protein kinase II (CaMKII). I Cl.Ca was also halved by inositol-3,4,5,6-tetrakisphosphate (IP4), a cellular signal with the biological function of specifically preventing CaMKII from activating I Cl.Ca . Gene disruption of ClC-3 reduced I Cl.Ca by 50%. Moreover, I Cl.Ca in the ClC-3 null VSMC was not affected by either KN-93 or IP4. We conclude that I Cl.Ca comprises two components: one is ClC-3 independent, while the other is ClC-3 dependent, activated by CaMKII, and inhibited by IP4. We also assayed VSMC migration in transwell assays. Migration was halved in ClC-3 null cells versus wild-type cells. Additionally, inhibition of ClC-3 by either niflumic acid, KN-93 or IP4, each reduced cell-migration in wild-type cells, but not in ClC-3 null cells. These cell-signaling roles of ClC-3 in VSMC migration suggest new therapeutic approaches to vascular remodeling diseases.
atherosclerosis chloride restenosis calcium CaMKII inositolphosphate

Details

Metrics

Logo image